KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) Gross Margin (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Gross Margin data on record, last reported at 94.93% in Q4 2025.

  • For Q4 2025, Gross Margin fell 999.0% year-over-year to 94.93%; the TTM value through Dec 2025 reached 90.6%, up 1367.0%, while the annual FY2025 figure was 90.6%, 20.0% down from the prior year.
  • Gross Margin reached 94.93% in Q4 2025 per CRL's latest filing, up from 92.27% in the prior quarter.
  • Across five years, Gross Margin topped out at 244.8% in Q4 2023 and bottomed at 34.47% in Q2 2024.
  • Average Gross Margin over 5 years is 80.23%, with a median of 82.85% recorded in 2024.
  • Peak YoY movement for Gross Margin: soared 11276bps in 2022, then plummeted -13987bps in 2024.
  • A 5-year view of Gross Margin shows it stood at 48.28% in 2021, then surged by 234bps to 161.04% in 2022, then skyrocketed by 52bps to 244.8% in 2023, then crashed by -57bps to 104.93% in 2024, then decreased by -10bps to 94.93% in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Margin were 94.93% in Q4 2025, 92.27% in Q3 2025, and 89.34% in Q2 2025.